Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Suppressing certain hormones might help prevent prostate cancer.

Minoxidil can reduce functions related to androgen receptors.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Clascoterone 1% cream is a promising new treatment for acne.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Effective delivery systems are crucial for siRNA hair loss treatments to work better.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.

High androgen levels cause skin issues in PCOS, affecting quality of life.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Muscles can make their own androgens, which may help muscle growth.

Regenerative medicine in Malaysia shows promise for treating diseases but faces ethical and safety challenges.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Maintaining healthy mitochondria may help treat hair loss.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.